12 Analysts Have This To Say About Humana
Portfolio Pulse from Benzinga Insights
Over the past three months, 12 analysts have evaluated Humana (NYSE:HUM), with a range of opinions from bullish to bearish. The average 12-month price target has increased by 3.72% to $388.0. Analysts have adjusted their ratings and price targets, reflecting their response to recent developments related to Humana. The company has shown impressive revenue growth but faces challenges with net margin and debt management.
October 01, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Analysts have mixed opinions on Humana, with a recent increase in the average price target to $388.0. The company shows strong revenue growth but faces challenges with net margin and debt management.
The article provides a detailed analysis of Humana's current standing among analysts, with a slight increase in the average price target. While the company shows strong revenue growth, it faces challenges with net margin and debt management, leading to a neutral short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100